| Authors: |
Jiang Y; Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden. yuan.jiang@ki.se., Xiao J; Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden.; Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, 610041, Chengdu, China., Kockum I; Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden., Stridh P; Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden., Liu Q; Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden., Olsson T; Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden., Alfredsson L; Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 17177, Sweden., Jiang X; Department of Clinical Neuroscience, The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden. xia.jiang@ki.se.; Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, 610041, Chengdu, China. xia.jiang@ki.se. |
